Texas Riverwalk Chapter Community

This community is available to ASCP members who have added the ASCP Texas Riverwalk Chapter to their membership.  Interested in joining this chapter and gaining access to the chapter's community?  Click to learn more!

 View Only
Back to discussions
Expand all | Collapse all

CDC Health Alert Network: Risk of Severe Arboviral Disease in Patients Receiving B Cell-Depleting or Modulating Medications - CDCHAN-00532

  • 1.  CDC Health Alert Network: Risk of Severe Arboviral Disease in Patients Receiving B Cell-Depleting or Modulating Medications - CDCHAN-00532

    ASCP Ambassador
    Posted 17 hours ago

    August 11, 2026

    The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to share information and notify clinicians, public health authorities, and the public about the risk of severe arboviral neuroinvasive disease among patients who are receiving B cell-depleting or B cell-modulating medications, particularly anti-CD20 monoclonal antibodies (mAbs). Patients and their providers should be aware of this risk to help patients protect themselves against the bites of mosquitoes and ticks, which can increase patients' risk of arboviral disease.

    VIEW FULL REPORT



    ------------------------------
    Rodney E. Rohde, PhD, MS, SM(ASCP)CM,SVCM,MBCM, FACSc
    Regents' Professor, Texas State University System
    University Distinguished Chair & Professor, Medical Laboratory Science [MLS] Program
    TEDx Speaker & Global Fellow – Global Citizenship Alliance
    Texas State Honorary Professor of International Studies
    Associate Director, Translational Health Research Initiative @txst_THR
    Past President, Texas Association for CLS

    Texas State University
    MLS Program, Encino Hall 350B [office ENC 363]
    601 University Drive
    San Marcos, TX 78666-4616
    512-245-3500 [CLS suite]; 512-245-2562 [office]
    Email: rrohde@txstate.edu
    Pronouns: he/him/his
    ------------------------------